AUD 1.12
(-5.51%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -3.03 Million AUD | -25.14% |
2022 | -5.35 Million AUD | -11.85% |
2021 | -4.19 Million AUD | 20.87% |
2020 | -4.86 Million AUD | -46.65% |
2019 | -4.07 Million AUD | -141.01% |
2018 | -1.46 Million AUD | -96.93% |
2017 | -1.34 Million AUD | -148.4% |
2016 | 1.54 Million AUD | -21.75% |
2015 | 4.25 Million AUD | -29.2% |
2014 | 871.27 Thousand AUD | 30459.22% |
2013 | -8.62 Million AUD | -150.82% |
2012 | 24.9 Thousand AUD | 114.91% |
2011 | 416.15 Thousand AUD | -112.31% |
2010 | 1.66 Million AUD | -64.72% |
2009 | 3.15 Million AUD | 55.02% |
2008 | 2.48 Million AUD | 28.67% |
2007 | 1.92 Million AUD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -7.55 Million AUD | 0.0% |
2023 Q4 | -6.32 Million AUD | 0.0% |
2023 FY | - AUD | -25.14% |
2023 Q2 | -2.41 Million AUD | 0.0% |
2022 Q2 | -1.66 Million AUD | 0.0% |
2022 Q4 | -4.68 Million AUD | 0.0% |
2022 FY | - AUD | -11.85% |
2021 Q2 | -3.19 Million AUD | 0.0% |
2021 Q4 | -2.64 Million AUD | 0.0% |
2021 FY | - AUD | 20.87% |
2020 FY | - AUD | -46.65% |
2020 Q4 | -2.68 Million AUD | 0.0% |
2020 Q2 | -4.48 Million AUD | 0.0% |
2019 FY | - AUD | -141.01% |
2019 Q4 | -2.71 Million AUD | 0.0% |
2019 Q2 | -2.17 Million AUD | 0.0% |
2018 Q4 | 1.26 Million AUD | 0.0% |
2018 FY | - AUD | -96.93% |
2018 Q2 | -1.17 Million AUD | 0.0% |
2017 Q4 | 2.35 Million AUD | 0.0% |
2017 FY | - AUD | -148.4% |
2017 Q2 | -1.02 Million AUD | 0.0% |
2016 Q2 | 823.58 Thousand AUD | 0.0% |
2016 Q4 | 1.18 Million AUD | 0.0% |
2016 FY | - AUD | -21.75% |
2015 Q4 | 1.88 Million AUD | 0.0% |
2015 FY | - AUD | -29.2% |
2015 Q2 | 349.87 Thousand AUD | 0.0% |
2014 Q2 | 644.87 Thousand AUD | 0.0% |
2014 FY | - AUD | 30459.22% |
2014 Q4 | 226.4 Thousand AUD | 0.0% |
2013 Q4 | 525.61 Thousand AUD | 0.0% |
2013 FY | - AUD | -150.82% |
2013 Q2 | -920.49 Thousand AUD | 58.5% |
2013 Q1 | -2.21 Million AUD | 0.0% |
2012 Q1 | 6227.50 AUD | 0.0% |
2012 Q2 | 6227.50 AUD | 0.0% |
2012 Q3 | 6227.50 AUD | 0.0% |
2012 FY | - AUD | 114.91% |
2012 Q4 | -2.21 Million AUD | -35719.52% |
2011 Q3 | -41.78 Thousand AUD | 0.0% |
2011 FY | - AUD | -112.31% |
2011 Q4 | 6227.50 AUD | 114.91% |
2011 Q1 | -41.78 Thousand AUD | 0.0% |
2011 Q2 | -41.78 Thousand AUD | 0.0% |
2010 Q1 | 339.31 Thousand AUD | 0.0% |
2010 FY | - AUD | -64.72% |
2010 Q4 | -41.78 Thousand AUD | -112.31% |
2010 Q3 | 339.31 Thousand AUD | 0.0% |
2010 Q2 | 339.31 Thousand AUD | 0.0% |
2009 Q3 | 788.8 Thousand AUD | 0.0% |
2009 Q4 | 339.31 Thousand AUD | -56.98% |
2009 FY | - AUD | 55.02% |
2009 Q1 | 788.8 Thousand AUD | 0.0% |
2009 Q2 | 788.8 Thousand AUD | 0.0% |
2008 Q3 | 620.4 Thousand AUD | 0.0% |
2008 Q2 | 620.4 Thousand AUD | 0.0% |
2008 Q1 | 620.4 Thousand AUD | 0.0% |
2008 FY | - AUD | 28.67% |
2008 Q4 | 788.8 Thousand AUD | 27.14% |
2007 Q4 | 620.4 Thousand AUD | 28.67% |
2007 Q1 | 482.18 Thousand AUD | 0.0% |
2007 Q3 | 482.18 Thousand AUD | 0.0% |
2007 Q2 | 482.18 Thousand AUD | 0.0% |
2007 FY | - AUD | 0.0% |
2006 Q4 | 482.18 Thousand AUD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
4DMedical Limited | -36.06 Million AUD | 91.585% |
Adherium Limited | -11.56 Million AUD | 73.757% |
Aroa Biosurgery Limited | -7.36 Million AUD | 58.765% |
Atomo Diagnostics Limited | -5.42 Million AUD | 44.042% |
Anteris Technologies Ltd | -66.9 Million AUD | 95.464% |
Control Bionics Limited | -5.15 Million AUD | 41.164% |
CardieX Limited | -6.71 Million AUD | 54.783% |
Compumedics Limited | 2.78 Million AUD | 208.817% |
Cochlear Limited | 579.5 Million AUD | 100.524% |
CleanSpace Holdings Limited | -3.49 Million AUD | 13.085% |
EMVision Medical Devices Ltd | -2.09 Million AUD | -45.127% |
Nova Eye Medical Limited | -5.97 Million AUD | 49.241% |
HeraMED Limited | -3.97 Million AUD | 23.594% |
Imricor Medical Systems, Inc. | -21.87 Million AUD | 86.123% |
ImpediMed Limited | -22.05 Million AUD | 86.237% |
InhaleRx Limited | -1.41 Million AUD | -114.671% |
LBT Innovations Limited | -4.04 Million AUD | 25.046% |
Micro-X Limited | -14.35 Million AUD | 78.852% |
Neurotech International Limited | -8.24 Million AUD | 63.187% |
OncoSil Medical Limited | -11.97 Million AUD | 74.659% |
PolyNovo Limited | 5.17 Million AUD | 158.702% |
Respiri Limited | -7.04 Million AUD | 56.951% |
SomnoMed Limited | -2.32 Million AUD | -30.331% |
Universal Biosensors, Inc. | -9.09 Million AUD | 66.614% |
Uscom Limited | -1.5 Million AUD | -101.079% |
Visioneering Technologies, Inc. | -4.91 Million AUD | 38.282% |